(S)-Cbz-Phenylalaninol
Synonym(s):(S)-(−)-2-(Carbobenzyloxyamino)-3-phenyl-1-propanol;(S)-2-(Z-Amino)-3-phenyl-1-propanol;N-(Carbobenzyloxy)-L -phenylalaninol
- CAS NO.:6372-14-1
- Empirical Formula: C17H19NO3
- Molecular Weight: 285.34
- MDL number: MFCD00191138
- EINECS: 1533716-785-6
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-01-13 11:22:52
What is (S)-Cbz-Phenylalaninol?
Chemical properties
white powder
The Uses of (S)-Cbz-Phenylalaninol
Employed in the synthesis of biochemically active compounds. Building block for the synthesis of HIV protease inhibitors.
Properties of (S)-Cbz-Phenylalaninol
| Melting point: | 92-95 °C |
| Boiling point: | 427.77°C (rough estimate) |
| alpha | -45 º (c=2, MeOH) |
| Density | 1.0864 (rough estimate) |
| refractive index | -42 ° (C=2, MeOH) |
| storage temp. | Sealed in dry,2-8°C |
| solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. |
| form | powder to crystal |
| pka | 11.86±0.46(Predicted) |
| color | White to Almost white |
| optical activity | [α]20/D 30°, c = 1 in chloroform |
| Water Solubility | insoluble |
| BRN | 2816420 |
| CAS DataBase Reference | 6372-14-1(CAS DataBase Reference) |
Safety information for (S)-Cbz-Phenylalaninol
| Signal word | Warning |
| Pictogram(s) |
![]() Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H302:Acute toxicity,oral H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
| Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P301+P312:IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. P302+P352:IF ON SKIN: wash with plenty of soap and water. P304+P340:IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for (S)-Cbz-Phenylalaninol
(S)-Cbz-Phenylalaninol manufacturer
ASM Organics
Andhra Pradesh
Phone:91-9866122393
Whatsapp: 91-9866122393
product: N-(Benzyloxycarbonyl)-L-phenylalaninol
New Products
Mirtazapine Impurity C/Mirtazapine Lactam Impurity Cyclopropane-1,1-dicarboxylic acid [1]Benzothieno[2,3-c]pyridine, 1,7-dichloro-8-methyl- (S)-3-Fluoro-pyrrolidine hydrochloride Cyclobutylamine 1-Bromo-2-Methoxy-3-Nitrobenzene 3-Oxocyclobutane-1-carboxylicacid (4-Bromophenyl)(3,4-dimethoxyphenyl)methanone N-Nitroso hydroxy Cetrizine EP Impurity-A Noradrenaline EP Impurity D/Noradrenaline Methyl Ether Cetirizine EP Impurity A/Cetirizine CBHP Impurity Lantanoprost rc B Clidinium Bromide Impurity 2-chloro-7-cyclopentyl-N,N-dimethylpyrrolo [2,3-d]pyrimidine-6-carbox amide 4-amino-2-fluoro-N- methylbenzamide N-(2-chloropyrimidin-4-yl)-N,2,3- trimethyl-2H- indazol 6-amine 5-Chloro-3- Methyl -1,3-2-benzoxazol-2(3H)-one 4-Bromo-2-fluoro-N-methylbenzamide N-Boc-1,4-butanediamine 4-Dimethylamino pyridine 2-Chlorotrityl Chloride 4-Bromoaniline 5-Bromo-2-chlorobenzoic acid 1,2,3,9-Tetrahydro-4(H)-carbazol-4-oneRelated products of tetrahydrofuran








You may like
-
6372-14-1 N-Benzyloxycarbonyl-L-phenylalaninol 99%View Details
6372-14-1 -
N-Carbobenzoxy-L-phenylalaninol CAS 6372-14-1View Details
6372-14-1 -
Cbz-L-Phenylalaninol 98% (HPLC) CAS 6372-14-1View Details
6372-14-1 -
KT-474 98+View Details
2432994-31-3 -
2,6-Piperidinedione, 3-hydroxy-1-[(4-methoxyphenyl)methyl]- 98+View Details
2357109-89-6 -
2,3-Difluoro-6-methoxybenzyl Chloride 98+View Details
1073435-67-2 -
2-(6-(benzyloxy)-3,4-dihydronaphthalen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 2477812-43-2 98+View Details
2477812-43-2 -
101894-09-1 4-Hydroxy-6-methyl-1-(4-methylphenyl)-2-naphthalenecarboxylic acid 98+View Details
101894-09-1
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

